Lombard Odier Asset Management (Usa) Corp Pfizer Inc Call Options Transaction History

Lombard Odier Asset Management (Usa) Corp

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	BUY	$25.89 - $29.73 $5.18 Million - $5.95 Million	200,000 Added 100.0%	400,000 $11.1 Million
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $7.29 Million - $9.49 Million	185,000 Added 1233.33%	200,000 $8.16 Million
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $28.3 Million - $42 Million	-685,000 Reduced 97.86%	15,000 $886,000
Q3 2021 Nov 12, 2021	SELL	$39.25 - $50.42 $5.89 Million - $7.56 Million	-150,000 Reduced 17.65%	700,000 $30.1 Million
Q2 2021 Aug 13, 2021	BUY	$35.91 - $40.68 $8.98 Million - $10.2 Million	250,000 Added 41.67%	850,000 $33.3 Million

Q1 2021 May 17, 2021	BUY	$33.49 - $37.77 $20.1 Million - $22.7 Million	600,000 New	600,000 $21.7 Million
Q2 2018 Aug 14, 2018	SELL	$32.98 - $35.16 $1.4 Million - $1.49 Million	-42,500 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$31.91 - $37.02 $1.36 Million - $1.57 Million	42,500 New	42,500 $1.51 Million

3,159

3.68B

67.4M

113M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Lombard Odier Asset Management (Usa) Corp, based on Form 13F filings with the SEC.

Stay updated on Lombard Odier Asset Management (Usa) Corp with notifications on news.